Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D
Gupta A, Premnath N, Sedhom R, Beg MS, Khera R, Laheru DA, Dusetzina SB. Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D. Pancreatology 2021, 21: 1009-1010. PMID: 34006458, DOI: 10.1016/j.pan.2021.05.002.Peer-Reviewed Original ResearchAgedEnzyme Replacement TherapyHealth ExpendituresHealth Services MisuseHumansInappropriate PrescribingMedicare Part DUnited States